Novartis AG vs Orion Office REIT Inc — how do they compare? Novartis AG trades at $152.38 (market cap $295.37B), while Orion Office REIT Inc trades at $2.72 (market cap $158.01M). The key difference: Novartis AG is far larger — about 1869.3× Orion Office REIT Inc's market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| NVS | ONL | |
|---|---|---|
Market Cap | $295.37B | $158.01M |
Sector | Health | Real Estate |
52-Week High | $168.62 | $3.04 |
52-Week Low | $119.31 | $1.93 |
Enterprise Value | $336.69B | $574.95M |
Dividend Yield | 3.07% | 2.89% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →